comprehensive -WSS

comprehensive

author：entertainment 2025-09-03 05:34:35 - browse：8

Several amyloid plaques forming between neurons in a brain — Adobe

Expert advisers to the Food and Drug Administration on Friday voted unanimously in favor of expanding the approval of Leqembi, an Alzheimer’s disease treatment from Eisai and Biogen, further clearing the way for what could be the first widely available medicine that delays the disease’s progress.

The group voted 6-0 that an 1,800-patient study of Leqembi confirmed its benefits for patients in the early stages of Alzheimer’s, recommending the FDA widen the drug’s limited approval. The agency, which is not required to follow the suggestions of its advisers, is expected to make a final decision on Leqembi by July 6.

“I thought the clinical results were robust,” said Merit Cudkowicz, a neurologist from Massachusetts General Hospital and one of the experts invited to review Leqembi.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Ebola public health emergency is over, WHO declares

WSS

Researchers separate signal from noise in heart wearable data

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Prosthetic arm enables patients to feel the objects they grip

Stigma and the return of syphilis

Startling documents reveal new facets of Sacklers' opioid empire

Addiction doctors spar with methadone clinics over legislation

knowledge

comprehensive

explore

At least 13 dead in Texas as scorching temps continue

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Medical leaders decry Supreme Court decision on affirmative action

Adam's Biotech Scorecard: Do Sarepta's exon

DIEP, the 'gold standard' of breast reconstruction, is under threat

David Sabatini, ex

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Dark money group runs ads on China biotech bill

hotspot

The kidney, in all its complexity, is captured in a new atlas

Biohaven protein

Prosthetic arm enables patients to feel the objects they grip

Latest bird flu infection made farmworker sicker than earlier cases

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Health insurers say they are turning to AI to cut costs, improve care

hotspot

knowledge

focus

focus